Shield Therapeutics Share Discussion Threads

[rafboy] 29/11/2019 07:18

Ok thanks.

[ny boy] 28/11/2019 23:23

Good things, good things. Can’t post it as it’s in a pdf but nothing that we don’t already know and wait excitedly for ie.US deal, China deal etc doesn’t mention share price predictions etc

That huge 1.375M buy @ 192p, must of been worked at for a while I reckon, should clear the way for a swift move above 200p soon imo

[rafboy] 28/11/2019 19:21

What did it say?

[ny boy] 28/11/2019 18:21

Good write up in shares magazine today, no doubt has attracted more buying.

[ny boy] 28/11/2019 16:58

They have been trying to force out a few sellers each day, by dropping the bid and widening the spread every so often. There is no reason to sell imo

[78steve] 28/11/2019 16:12

Looking bit more promising today. It went up like this a short while ago then it dropped back by end of the day on same day it had risen

[crankyman] 28/11/2019 16:08

That's not free float stock, surely.

[ny boy] 28/11/2019 15:55

Monty was that your top up?

[ny boy] 28/11/2019 15:45

Next resistance according to the stats here




1.375M buy @ 192p, that will gobble up a lot of free float, expecting some rapid moves north, v. Soon!

[montyhedge] 28/11/2019 15:43

Shareprice talks this shouting deal any day. Always someone knows more than us.

[rafboy] 28/11/2019 15:34

1.3M share buy!

[martindkelly9] 28/11/2019 14:54

How can there be resistance at 222.39p? The ATH is 202p. Do you mean that profit-taking may occur at 222.39p?

[ny boy] 28/11/2019 14:04

Resistance 1 : 190.40p Resistance 2: 222.39p

A close above 190.40p, opens up a move to 222.39p at least, I say that as a US commercialization deal will see the share price smash through 222.39p

[78steve] 28/11/2019 13:35

See where we end up at end of day

[rafboy] 28/11/2019 13:24

Nice move up today. We are close to announcements on licence deals so not surprised people are buying in.

[ny boy] 28/11/2019 12:41

Sp action of late is showing signs of normal activity, not long before we break 200p

A greatly de-risked hold since FDA broad label approval end July.

Hopefully exciting times ahead.

[crankyman] 28/11/2019 12:23

OK, thanks. A hiding to nothing then. Under-capitalised from the start. They needed a better phase II programme for a drug like that. It's great (for the patients at least) it's getting a second chance. It's not a great analogue for STX.

[nobbygnome] 28/11/2019 12:10

>> cranky

IMM weren't in a good position because the previous phase III showed Lupuzor conclusively didn't work at the dose used. The p value was 0.27 from memory. Avion are taking a big risk and hence no upfront and low royalties. They will no doubt have an inclusion criteria of anti DNA abs but interestingly that didn't have a signal in the US when they did the post hoc analysis only in Europe. You couldn't make it up!

[crankyman] 28/11/2019 11:56

Norgine pay 25% and up to 40% if they surpass target. But no milestones I believe.

[crankyman] 28/11/2019 11:55

Pretty good agreement - for Avion. 17% royalty. No upfront. Ouch. And it still rises 2 + times

[ny boy] 28/11/2019 11:14

Yeah Monty I bought a couple of chunks in (IMM), sold one and holding the other as a core. Could turn into a monster rise over time, remember these sunk to 15p and change.

Onwards & upwards here, keeping in mind, from memory, only 15% of shares not in Directors/institutional hands.

Hopefully a nice rns before Xmas

[montyhedge] 28/11/2019 10:56

Look what can happen to a shareprice on a deal signed, Immupharma up 268% this morning on a signed deal. Just waiting for our deal boys, then big celebration for Xmas.
I see 275p.

[nobbygnome] 28/11/2019 10:40

Looking perky again this morning. Will it hold this time? A deal will inevitably come whether it is before Christmas or not!

[ny boy] 28/11/2019 09:26

I have NFX, just don’t need to buy anymore.

Bought (IMM) for a spec gamble now Avion are funding US Phase 3 trials to $25M

Not much free float here, expecting a big move up soon as we approach end of year.